BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

KIRK PHARMACEUTICALS — Lobbying — Receipts Report

LD-2 disclosure · 1st Quarter - Report

KIRK PHARMACEUTICALS

via VAN FLEET ASSOCIATES

1st Quarter (Jan 1 - Mar 31) · 2008Posted Apr 7, 2008Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: KIRK PHARMACEUTICALS
Description: Pharmaceutical products
Location: Florida · United States of America

Registrant

Firm: VAN FLEET ASSOCIATES
Description: Government Relations (Includes Lobbying)
Location: Alexandria, Virginia, United States of America

Lobbying activities

1 issue

Pharmacy
FDA and DEA regulation pertaining to over the counter drug sales.
TargetedSENATE · HOUSE OF REPRESENTATIVES · Food & Drug Administration (FDA) · Drug Enforcement Administration (DEA)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.